Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
PaperCitations, authors & open-access status
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 279 citations, 2020 year and hybrid oa status.
279
Citations
2020
Year
hybrid
OA Status